首页> 美国卫生研究院文献>SpringerPlus >Ultrasound assessment of the median nerve: a biomarker that can help in setting a treat to target approach tailored for carpal tunnel syndrome patients
【2h】

Ultrasound assessment of the median nerve: a biomarker that can help in setting a treat to target approach tailored for carpal tunnel syndrome patients

机译:超声评估正中神经:一种生物标记物可帮助制定针对腕管综合症患者的针对性治疗方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ultrasonography (US) is a valuable tool for confirming the diagnosis of carpal tunnel syndrome (CTS) as it enables the detection of changes in the median nerve shape and rule out anatomic variants as well as space-occupying lesions such as ganglion cysts or tenosynovitis. This work was carried out aiming at: 1. Ultrasonography assessment of the median nerve and its neurovascular blood-flow in CTS patients before and after management. 2. Verify the possibility of using baseline US parameters as a biomarker to predict likely outcomes and frame a treatment plan for CTS patients.233 CTS subjects diagnosed based on clinical and electrophysiological (NCS) testing were included in this work. US measures at the tunnel inlet included: cross sectional area, flattening ratio and neural Power Doppler (PD) signals. Patients who had severe NCS outcomes or neurological deficit were referred for open surgical decompression; the remaining patients were given the choice of either conservative or surgical management. The main outcome variable was improvement >70% in CTS symptoms. Assessments were carried out at baseline, 1-week, 1-month and 6-months post treatment. Results revealed an inverse relation between the neural vasculature and CTS severity defined by NCS (r = − 0.648). In CTS cases treated conservatively, the US measures started to improve within 1-week, whereas in the surgically treated cohort there was an initial phase of post-operative nerve measures increase, before settling at 1-month time of follow-up. The risk of poor outcomes was significantly higher (RR 3.3) in patients with high median nerve flattening ratio. This risk was most marked in the cohort with nerve flattening associated with longer duration of illness (RR 4.3) and low PD signal (RR 4.1). The results revealed that in addition to the diagnostic value of US in CTS, the detection of increased median nerve neuro-vasculature has a good prognostic value as an indicator of early median nerve affection.
机译:超声检查(US)是确定腕管综合症(CTS)诊断的有价值的工具,因为它可以检测中位神经形状的变化并排除解剖学变异以及诸如神经节囊肿或腱鞘炎等占位性病变。开展这项工作的目的是:1.超声检查CTS患者治疗前后的正中神经及其神经血管血流。 2.验证使用基线US参数作为生物标志物来预测可能的结局并制定CTS患者治疗计划的可能性。该工作包括233位根据临床和电生理学(NCS)测试诊断出的CTS对象。美国在隧道入口处的措施包括:截面积,展平率和神经动力多普勒(PD)信号。具有严重NCS结局或神经功能缺损的患者应进行开放性手术减压。其余患者可以选择保守治疗或手术治疗。主要结局变量是CTS症状改善> 70%。在治疗后的基线,1周,1个月和6个月进行评估。结果揭示了神经脉管系统和由NCS定义的CTS严重程度之间呈反比关系(r =-0.648)。在保守治疗的CTS病例中,US措施在1周内开始改善,而在接受手术治疗的队列中,术后神经措施的初始阶段有所增加,然后在1个月的随访时间安定下来。中位数神经扁平率高的患者预后不良的风险显着更高(RR 3.3)。在该人群中,这种风险最明显的表现为神经扁平,伴有疾病持续时间较长(RR 4.3)和PD信号低(RR 4.1)。结果显示,除了US在CTS中的诊断价值外,增加中位神经神经脉管系统的检测作为早期中位神经病变的指标具有良好的预后价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号